Balaji Amines Ltd
Balaji Amines Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #21 of 71 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
Expecting a minimum 15% growth in values and volumes in the next financial year as new plants commission and run at optimum capacity (Page 7). Company expects at least 15% growth in volume and value in the next financial year, driven by commissioning of new plants and expansions (Page 7).
From Balaji Amines Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Expecting a minimum 15% growth in values and volumes in the next financial year as new plants commission and run at optimum capacity (Page 7).
- Anticipate 7%-8% domestic market consumption growth for acetonitrile driven by cost-effective, user-friendly product demand in pharma (Page 9).
- Specialty Chemicals subsidiary revenue expected to remain similar to H1 FY '26 (~INR70 crores), with improvements post completion of brownfield modifications (Page 9).
- Volume growth of 8%-10% expected in the second half of FY '26 as approvals and market demand revive (Page 5).
- Gradual traction expected in the second half of FY '26 as new capacities commission and demand strengthens (Page 4).
2 more points from Balaji Amines Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Balaji Amines Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Balaji Specialty Chemicals Limited is executing a INR750 crores expansion plan with mega project status under Maharashtra's Package Scheme of Incentives 2019.
- Unit 1 brownfield expansion for EDA-based products expected commissioning by September 2026.
- Unit 2 greenfield project at Chincholi progressing with equipment installation; commissioning expected by December 2026.
- New plants like DME (dimethyl ether) and N-methylmorpholine are under commissioning, expected by end of FY 2025-26.
- Acetonitrile plant expansion with improved technology slated for commissioning in FY 2026-27.
- All ongoing projects are being funded through internal accruals; company maintains zero debt and good cash position.
2 more points from Balaji Amines Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Balaji Amines Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company mentions ongoing contracts and export orders, especially in the U.S. and Europe, with continuation and renewal signals for the coming financial year.
- Exports are currently limited due to capacity constraints and brownfield modifications but expected to pick up post-expansion.
- Domestic demand is stable with gradual recovery noted in pharma and agrochemical segments.
- Upcoming projects and expansions (e.g., Unit 1 brownfield and Unit 2 greenfield) are expected to enhance capacity and drive new orders.
2 more points from Balaji Amines Ltd's call on order book
Create a free account to keep reading this call
Balaji Amines Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹395 Cr, net profit ₹65 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Balaji Amines's management said in earlier quarters
- Q3 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q4 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q4 FY22 earnings call →
- Q3 FY22 earnings call →
Others in Chemicals & Petrochemicals this season
- Gujarat Alkalies (Q2 FY26)
2,136.64 Crores (Page 21). Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation — and how it ranks against
- Dynemic Products Ltd (Q2 FY26)
Quarterly revenue for Q2 FY 25-26: ₹8,935 lakhs (Page 12, 10, 5) . Key investor presentation takeaways from Dynemic Products's Q2 FY26 investor presentation — a
- Platinum Industries Ltd (Q2 FY26)
Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri
- IVP Ltd (Q2 FY26)
Revenue from Operations for Q2FY26: ₹146.95 crores . Key investor presentation takeaways from IVP's Q2 FY26 investor presentation — and how it ranks against sec
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Balaji Amines Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Balaji Amines Ltd Q2 FY26 results?
Expecting a minimum 15% growth in values and volumes in the next financial year as new plants commission and run at optimum capacity (Page 7). Company expects at least 15% growth in volume and value in the next financial year, driven by commissioning of new plants and expansions (Page 7).
What is Balaji Amines Ltd share price analysis?
Balaji Amines Ltd currently shows a neutral. The stock trades at a P/E of 33.9 with a market cap of ₹6,914 Cr. Investors should review the full earnings analysis for detailed insights.
Is Balaji Amines Ltd planning capital expenditure?
Balaji Specialty Chemicals Limited is executing a INR750 crores expansion plan with mega project status under Maharashtra's Package Scheme of Incentives 2019.
Keep Balaji Amines Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.